Get started
Author

Maria Pia Abruzzese

Observed names: M Abruzzese, M. Abruzzese
ORCID: 0000-0003-4433-4670
Observed ORCID: 0000-0003-4433-4670
OpenAlex ID: A5007973270
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis
2017 · Elisabetta Vulpis, Francesca Cecere, et al. · OncoImmunology · 121
PDF
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
2016 · Maria Pia Abruzzese, Maria Teresa Bilotta, et al. · Journal of Hematology & Oncology · 94
PDF
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma
2015 · Cinzia Fionda, Maria Pia Abruzzese, et al. · Oncotarget · 89
PDF
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
2015 · Cinzia Fionda, Maria Pia Abruzzese, et al. · BMC Cancer · 65
PDF
Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer
2016 · Cinzia Fionda, Maria Pia Abruzzese, et al. · Current Medicinal Chemistry · 49
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells
2016 · Alessandra Soriani, Cristiana Borrelli, et al. · OncoImmunology · 34
PDF
Activation of liver X receptor up‐regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms
2019 · Maria Teresa Bilotta, Maria Pia Abruzzese, et al. · The FASEB Journal · 26
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors
2019 · Maria Pia Abruzzese, Maria Teresa Bilotta, et al. · Cell Death and Disease · 18
PDF
GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study
2023 · Antonella Tramutola, Hannah S. Bakels, et al. · EBioMedicine · 17
PDF
Testicular endocrine function in dystrophia myotonica (Steinert's disease).
1975 · G Lotti, M Abruzzese, et al. · PubMed · 2
H11 The lirh foundation HD observational studies: enroll-HD and HDclarity
2022 · Ludovica C Busi, Consuelo Ceccarelli, et al.
A20 Reduced levels of the glucose transporter glut-1 in brain striatum and periphery reveals clues to specific pathomechanisms in childhood-onset Huntington disease
2022 · Federica Perrone, Hannah Bakels, et al.
Is clinical variability in CMT1A related to epigenetic factors?
2004 · L Benedetti, R Zuccarino, et al. · Journal of the Peripheral Nervous System
Expression of ciliary neurotrophic factor (CNTF) in charcot‐marie‐tooth type 1A (CMT1A) disease
2004 · T Vigo, A Schenone, et al. · Journal of the Peripheral Nervous System
Phenotype of Pmp22 Transgenic Schwann Cells in Culture
2002 · L. Nobbio, T. Vigo, et al. · Journal of the Peripheral Nervous System
Works count: 15
Citation count: 515
H-index: 9
I10-index: 9
Year
Topic
Type